checkAd
    Startseite > Aktien > G1 Therapeutics > Nachrichten
    G1 Therapeutics Aktie
    3,7500
     
    USD
    -6,02 %
    -0,2400 USD
    Letzter Kurs 00:27:34 Nasdaq
    3,7100
     
    USD
    1.500 STK
    Geldkurs 29.04.24
    3,7200
     
    USD
    100 STK
    Briefkurs 29.04.24
    ISIN: US3621LQ1099 · WKN: A2DR0J · SYM: GTHX · USA

    Neueste Nachrichten

    G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
    17.04.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    04.04.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.04.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
    28.02.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
    27.02.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
    15.02.24 · globenewswire · G1 Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 13.02.2024
    13.02.24 · wO Chartvergleich · Deutsche Boerse
    G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
    12.02.24 · globenewswire · G1 Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 06.02.2024
    06.02.24 · wO Chartvergleich · Celanese
    G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
    08.01.24 · globenewswire · G1 Therapeutics
    G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · G1 Therapeutics